enzymes x AI = exozymes
A paradigm shift in chemical production through AI-driven exozymes to create sustainable, non-toxic alternatives to petrochemicals.
Chemicals are everywhere around us. They're in our medicine, fuel, plastic, food, and most colors, to name a few applications. Biochemical extraction is often inefficient, and petrochemical production is toxic and polluting. However - for the first time in history – we now have the tools and insight to control and optimize nature’s own biological processes, enabling us to replace traditional chemical production methods with a sustainable and eco-friendly alternative: Exozymes.
Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells. Exozyme biosolutions allow us to efficiently transform affordable and widely available feedstocks into a diverse range of valuable small-molecule chemicals, including active pharmaceutical ingredients, nutraceuticals, and biofuel.
What is exozymes?
Exozymes are advanced enzymes engineered with AI to thrive in a bioreactor outside of living cells. Exozyme biosolutions transform affordable, widely available feedstocks like sugar and biomass into a diverse range of valuable small-molecule chemicals. These include active pharmaceutical ingredients for medicines as well as biofuels, to name a few but highly important use cases.
The story of Invizyne
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet consectetur. Integer eget magna mollis eleifend. Ullamcorper eu mauris luctus amet nullam.
- Lorem ipsum dolor sit amet consectetur.
- Integer eget magna mollis eleifend.
- Ullamcorper eu mauris luctus amet nullam.
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet consectetur. Integer eget magna mollis eleifend. Ullamcorper eu mauris luctus amet nullam.
- Lorem ipsum dolor sit amet consectetur.
- Integer eget magna mollis eleifend.
- Ullamcorper eu mauris luctus amet nullam.
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet consectetur. Integer eget magna mollis eleifend. Ullamcorper eu mauris luctus amet nullam.
- Lorem ipsum dolor sit amet consectetur.
- Integer eget magna mollis eleifend.
- Ullamcorper eu mauris luctus amet nullam.

Michael Heltzen
CEO

Tyler Korman, PhD
Co-Founder & VP of Research

Paul Opgenorth, PhD
Co-Founder & VP of Development

Zach Karl, PhD
VP of Business Development

Fouad Nawaz
VP of Finance

Lasse Görlitz
VP of Comms
Latest presentation
Explore our latest investor presentation to gain insights into Invizyne’s financial performance, strategic initiatives, and growth prospects. This comprehensive overview provides key information to help investors understand our market positioning and future opportunities.

Investor Relation Contacts:
Corporate Headquarters
Suite 106
Monrovia, CA 91016
(626) 415-1488
Investor Relations
Lasse Görlitz
VP of Communications
(858) 319-7135
press@exozymes.com
Transfer Agent
VStock Transfer, LLC.
18 Lafayette Place
Woodmere, New York 11598
(212) 828-8436

Christopher Marlett
Chairman of the Board

Anthony DiGiandomenico
Board Member

Edgardo Rayo
Board member

Jim Lalonde, Ph.D.
Board Member, Formerly SVP of R&D Codexis

Lon Bell
Board Member, CEO of DTP Thermoelectri

James Bowie, Ph.D.
Co-Founder & Board Member, Professor Emeritus, Department of Chemistry & Biochemistry at UCLA
Committee Composition
Audit Committee | Nominating and Corporate Governance Committee | Human Resource & Compensation Committee | |
---|---|---|---|
Lon Bell | |||
Jim Bowie | |||
James Lalonde |
Committee Chair. Committee Member